Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | AS605240 | 1 | 72 | 1.0 | 5369.8 | 6371.0 | 1443.3 | 0.0 | 0.847 | 0.843 | 2.142 | BT20 AS605240 0 1 |
| BT-20 | AS605240 | 1 | 72 | 0.32 | 5530.8 | 6371.0 | 1443.3 | -0.495 | 0.872 | 0.868 | 2.142 | BT20 AS605240 0 1 |
| BT-20 | AS605240 | 1 | 72 | 0.1 | 5634.5 | 6371.0 | 1443.3 | -1.0 | 0.889 | 0.884 | 2.142 | BT20 AS605240 0 1 |
| BT-20 | AS605240 | 1 | 72 | 0.032 | 5869.3 | 6371.0 | 1443.3 | -1.49 | 0.925 | 0.921 | 2.142 | BT20 AS605240 0 1 |
| BT-20 | AS605240 | 1 | 72 | 0.01 | 6095.5 | 6371.0 | 1443.3 | -2.0 | 0.959 | 0.957 | 2.142 | BT20 AS605240 0 1 |
| BT-20 | AS605240 | 1 | 72 | 0.0032 | 6003.8 | 6371.0 | 1443.3 | -2.49 | 0.945 | 0.942 | 2.142 | BT20 AS605240 0 1 |